Author

Jeffrey Johnson

ATUM (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1

Frequent Co-Authors

BRANDON MARTIN· 1 shared Divya Teja Vavilala· 1 shared Emily Cronberger· 1 shared Emily Richardson· 1 shared Ferenc L. BoldogiD· 1 shared Gena M. Dominique· 1 shared Ijeoma Asilebo· 1 shared Indira Kottayil· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

BRANDON MARTIN

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Metabolic Targeting of SREBP1 Reprograms the Obesity-Driven Ascites Immune Microenvironment and Enhances Chemotherapy Response in Obesity-Associated Ovarian Cancer

Jing Yang, Tyvette S. Hilliard, Yueying Liu, Emily Richardson, SOPHIA SANTOSO, Viktoriia Khomenko, Molly B. Conroy, BRANDON MARTIN, Emily Cronberger, Gena M. Dominique, Zhikun Wang, JEFFREY JOHNSON, Wanrui Wang, Ijeoma Asilebo, Mary Sharon Stack

This study shows that inhibiting SREBP1 with Nelfinavir improves chemotherapy response in obesity-associated ovarian cancer by reprogramming the immune microenvironment.

bioRxiv · Sep 16, 2026 · PreprintCancer Biology

Cell Line Development for Bispecific Antibodies: Better Predictability Through Transposases

Sowmya Rajendran, Indira Kottayil, Lynn Webster, Divya Teja Vavilala, Molly Hunter, Monica Konar, Surya Karunakaran, Mário José dos Santos Pereira, Jeffrey Johnson, Jeremy Minshull, Ferenc L. Boldog

This paper shows that using the Leap-In transposon platform improves predictability in developing bispecific antibody-producing cell lines by enabling stable pools with predictable productivity and heterodimer fractions.

bioRxiv · Aug 12, 2025 · PreprintBioengineering